Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Traceability of Counterfeit Drugs in Pharma Supply Chain Through Blockchain Technology - a Systematic Review of the Evidence


Affiliations
1 Department of Commerce, Manipal Academy of Higher Education, Manipal – 576104 Dist - Udupi (Karnataka), India
2 Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576104 Dist - Udupi (Karnataka), India
3 Department of Data Science and Computer Applications, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal – 576104 Dist - Udupi (Karnataka), India
     

   Subscribe/Renew Journal


Effectively managing the pharma supply chain is crucial in order to ensure optimal safety of drugs. Various issues pertained to pharma logistics is evident namely shortage of medicines, fake medicines, vulnerabilities in security, etc., highlights the failures in pharma supply chain and the high stakes involved in this sector in comparison to any other sector. The study incorporates the guidelines of PRISMA in order to synthesize the literature. This paper makes an honest attempt to discuss the glitches in the pharma supply chain due to faulty systems in place. It further deliberates on the need for the implementation of blockchain so as to enable a fool-proof track and trace system which goes on to avoid the occurrence of counterfeit drugs in the supply chain. This perspective highlights the opportunities that blockchain has, in the area of pharma supply chain and how vital it is for future adoption and implementation.

Keywords

Pharma supply chain, Logistics, Counterfeit drugs, Review, Challenges.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Garankina, R. Y., Zakharochkina, E. R., Samoshchenkova, I. F., Lebedeva, N. Y., and Lebedev, A. V. Blockchain Technology and its Use in the Area of Circulation of Pharmaceuticals. Journal of Pharmaceutical Sciences and Research. (2018); 10(11): 2715-2717.

  • Bagozzi D, Lindmeier C. World Health Organization. 1 in 10 medical products in developing countries is substandard or falsified: WHO Urges Governments to take action. 2018; (11).

  • Clauson, K. A., Breeden, E. A., Davidson, C., and Mackey, T. K. Leveraging blockchain technology to enhance supply chain management in healthcare: an exploration of challenges and opportunities in the health supply chain. Blockchain in Healthcare Today. (2018); 1(3): 1-12.

  • Sylim, P., Liu, F., Marcelo, A., and Fontelo, P. Blockchain technology for detecting falsified and substandard drugs in distribution: pharmaceutical supply chain intervention. JMIR Research Protocols. (2018); 7(9): e10163.

  • Jochumsen, M. L., and Chaudhuri, A. Blockchain‘s impact on supply chain of a pharmaceutical company. In EUROMA Conference 2018; (6).

  • Kumar, R., and Tripathi, R. Traceability of counterfeit medicine supply chain through Blockchain. In 2019 11th International Conference on Communication Systems and Networks (COMSNETS). 2019; (1): 568-570.

  • Brechtelsbauer, E. D., Pennell, B., Durham, M., Hertig, J. B., and Weber, R. J. Review of the 2015 Drug Supply Chain Security. (2016); 51(6): 493-500.

  • World Health Organization. 1 in 10 medical products in developing countries is substandard or falsified. 2017; (11). Available URL: https://www.who.int/en/news-room/detail/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified

  • Wu, H., Li, Z., King, B., Ben Miled, Z., Wassick, J., and Tazelaar, J. A distributed ledger for supply chain physical distribution visibility. Information. (2017); 8(4): 137.

  • Alangot, B., and Achuthan, K. Trace and track: Enhanced pharma supply chain infrastructure to prevent fraud. In International Conference on Ubiquitous Communications and Network Computing. 2017; 218(8): 189-195.

  • Soundarya, K., Pandey, P., and Dhanalakshmi, R. A Counterfeit Solution for Pharma Supply Chain. EAI Endorsed Transactions on Cloud Systems. 2018; 3(11): e5.

  • Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D., and White, N. J. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med. 2005; 2(4): e100.

  • Kim, H. M., and Laskowski, M. Toward an ontology‐driven blockchain design for supply‐chain provenance. Intelligent Systems in Accounting, Finance and Management. 2018; 25(1): 18-27.

  • Abeyratne, S. A., and Monfared, R. P. Blockchain ready manufacturing supply chain using distributed ledger. International Journal of Research in Engineering and Technology. 2016; 5(9): 1-10.

  • Mackey, T. K., and Nayyar, G. A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert Opinion on Drug Safety. 2017; 16(5): 587-602.

  • Forbes - Stephanie Overby. Transforming Transaction Processing for the Digital Economy. Forbes. 2016; 11: 1-9.

  • Haq, I., and Esuka, O. M. Blockchain technology in pharmaceutical industry to prevent counterfeit drugs. Int. J. Comput. Appl. 2018; 180(25): 8-12.

  • Jangir, S., Muzumdar, A., Jaiswal, A., Modi, C. N., Chandel, S., and Vyjayanthi, C. A Novel Framework for Pharmaceutical Supply Chain Management using Distributed Ledger and Smart Contracts. In 2019 10th International Conference on Computing, Communication and Networking Technologies (ICCCNT). 2019; 7: 1-7.

  • Vujičić, D., Jagodić, D., and Ranđić, S. Blockchain technology, bitcoin, and Ethereum: A brief overview. In 2018 17th International Symposium Infoteh-Jahorina (infoteh). 2018; 3: 1-6.

  • Shanley, A. Could Blockchain improve pharmaceutical supply chain security. Pharmaceutical Technology. 2017; 41(8): 34-39.

  • Nakamoto, S. Bitcoin: A peer-to-peer electronic cash system. Manubot. 2019.

  • Mettler, M. Blockchain technology in healthcare: The revolution starts here. In 2016 IEEE 18th International Conference on e-Health Networking, Applications and Services (Healthcom). 2016; 9: 1-3.

  • Kurki, J. Benefits and guidelines for utilizing blockchain technology in Pharmaceutical supply chains: case Bayer Pharmaceuticals. 2016.

  • van der Meulen, R. Gartner Says 6.4 Billion Connected “Things” Will Be in Use in 2016, Up 30 Percent From 2015. 2015. 2016. Available URL: https://www. gartner. com/newsroom/id/3165317 (visited on 05/23/2016).

  • Brechtelsbauer, E. D., Pennell, B., Durham, M., Hertig, J. B., and Weber, R. J. Review of the 2015 Drug Supply Chain Security. 2016.

  • European Medicines Agency, “Falsified Medicines Directive”. 2018; 25(1). Available URL:https://ec.europa.eu/health/human-se/falsifiemedicines-en


Abstract Views: 94

PDF Views: 0




  • Traceability of Counterfeit Drugs in Pharma Supply Chain Through Blockchain Technology - a Systematic Review of the Evidence

Abstract Views: 94  |  PDF Views: 0

Authors

Adithya D. Shetty
Department of Commerce, Manipal Academy of Higher Education, Manipal – 576104 Dist - Udupi (Karnataka), India
Sandeep S. Shenoy
Department of Commerce, Manipal Academy of Higher Education, Manipal – 576104 Dist - Udupi (Karnataka), India
D. Sreedhar
Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576104 Dist - Udupi (Karnataka), India
Ankitha Shetty
Department of Commerce, Manipal Academy of Higher Education, Manipal – 576104 Dist - Udupi (Karnataka), India
Rohini Rao
Department of Data Science and Computer Applications, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal – 576104 Dist - Udupi (Karnataka), India
Komal Jenifer D’souza
Department of Commerce, Manipal Academy of Higher Education, Manipal – 576104 Dist - Udupi (Karnataka), India

Abstract


Effectively managing the pharma supply chain is crucial in order to ensure optimal safety of drugs. Various issues pertained to pharma logistics is evident namely shortage of medicines, fake medicines, vulnerabilities in security, etc., highlights the failures in pharma supply chain and the high stakes involved in this sector in comparison to any other sector. The study incorporates the guidelines of PRISMA in order to synthesize the literature. This paper makes an honest attempt to discuss the glitches in the pharma supply chain due to faulty systems in place. It further deliberates on the need for the implementation of blockchain so as to enable a fool-proof track and trace system which goes on to avoid the occurrence of counterfeit drugs in the supply chain. This perspective highlights the opportunities that blockchain has, in the area of pharma supply chain and how vital it is for future adoption and implementation.

Keywords


Pharma supply chain, Logistics, Counterfeit drugs, Review, Challenges.

References